Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

July 10, 2023 updated by: Dr. Kevin C. Chung, University of Michigan
This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research will determine if one surgery is better than the other to alleviate symptoms.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

378

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30329
        • Recruiting
        • Emory Healthcare
        • Principal Investigator:
          • Eric Wagner, MD
        • Contact:
    • Kentucky
      • Louisville, Kentucky, United States, 40241
    • Maryland
      • Baltimore, Maryland, United States, 21218
        • Recruiting
        • Curtis National Hand Center
        • Contact:
        • Principal Investigator:
          • Aviram Giladi, MD, MS
      • Baltimore, Maryland, United States, 21093
        • Terminated
        • Johns Hopkins University
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Recruiting
        • Michigan Medicine
        • Contact:
        • Principal Investigator:
          • Kevin Chung, MD, MS
    • North Carolina
      • Charlotte, North Carolina, United States, 28207
        • Recruiting
        • OrthoCarolina Research Institute, Inc.
        • Contact:
        • Principal Investigator:
          • R. Glenn Gaston, MD
      • Winston-Salem, North Carolina, United States, 27157
        • Recruiting
        • Wake Forest University Health Sciences
        • Contact:
        • Principal Investigator:
          • Zhongyu Li, MD, PhD
    • Ohio
      • Columbus, Ohio, United States, 43210
        • Recruiting
        • Ohio State University
        • Contact:
        • Principal Investigator:
          • Sonu A Jain, MD
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73126
        • Recruiting
        • University of Oklahoma
        • Contact:
        • Principal Investigator:
          • Thomas Lehman, MD
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • Recruiting
        • University of Pittsburgh Medical Center
        • Contact:
        • Principal Investigator:
          • John R. Fowler, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • A clinical diagnosis or suspected diagnosis of isolated ulnar neuropathy at the elbow
  • Confirmation of ulnar neuropathy using the American Association of Electrodiagnostic Medicine criteria for electrodiagnostic studies at the elbow. (Participants must meet at least 1 of the criteria to be enrolled (absolute motor nerve conduction from above elbow (AE) to below elbow (BE) of less than 50 m/s; An AE to BE segment greater than 10 m/s slower than BE to wrist segment; A decrease in compound muscle action potential (CMAP) negative peak amplitude from BE to AE greater than 20%)
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Able to read, understand and complete the questionnaires in English

Exclusion Criteria:

  • Previous elbow fracture requiring surgical fixation
  • Patients who have not attempted conservative management for UNE (e.g. night splinting)
  • Subluxation of ulnar nerve on preoperative exam
  • Recurrent UNE after previous surgery
  • Concomitant neuropathic conditions such as Carpal Tunnel Syndrome or cervical or brachial plexus abnormalities
  • Participants with severe comorbid conditions that prohibit surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Simple decompression
In-situ decompression releases only the compressive ligamentous structures overlying the ulnar nerve.
Surgical technique
Other Names:
  • In-situ Decompression
Active Comparator: Subcutaneous anterior transposition
Anterior transposition repositions the ulnar nerve, providing decompression and lengthening by moving the nerve anterior to the axis of elbow rotation
Surgical technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of surgery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) summary score
Time Frame: 1 year
The MHQ is a self-report measure that assesses the function of the hand(s) and/or wrist(s). The MHQ contains six distinct scales assessing overall hand function, activities of daily living, pain, work performance, aesthetics and subject satisfaction with hand function. Scores range from 0-100, 100=no disability). In the pain scale, however, high scores indicate greater pain (0-100, 0=no pain).
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recovery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) pain score
Time Frame: Up to 1 year
The MHQ is a self-report measure that assesses the function of hand(s) and/or wrist(s). The MHQ contains six distinct scales. The score will be measured at various time points to identify the recovery trend.In a pain scale, high scores indicate greater pain (0-100, 0=no pain)
Up to 1 year
Recovery as assessed by the Carpal tunnel questionnaire (CTQ) symptom score
Time Frame: Up to 1 year

The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.

The score will be measured at various time points to identify the recovery trend.

Up to 1 year
Recovery as assessed by the Carpal tunnel questionnaire (CTQ) pain score
Time Frame: Up to 1 year

The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.

The score will be measured at various time points to identify the recovery trend.

Up to 1 year
Difference in Grip Strength (unaffected hand - affected hand) measured by a Jamar dynamometer
Time Frame: Up to 1 year
Measured in kilograms. Grip strength will be measured at various time points to identify the recovery trend.
Up to 1 year
Difference in Pinch Strength (unaffected hand - affected hand) as measured by a pinch gauge
Time Frame: Up to 1 year
Pinch strength will be recorded, to the nearest half-kilogram. It will be measured at various time points to identify the recovery trend.
Up to 1 year
Difference in distance assessed by the 2 Point Discrimination (unaffected hand - affected hand)
Time Frame: Up to 1 year
Thresholds on the tip of the finger of both hands are assessed using the method of constant stimuli. One single needle and seven pairs of needles with different spacing's are tested in randomized order. After each presentation, the subject has to report the sensation of one or two needles by answering immediately "one" or "two." The threshold difference will be measured at various time points to identify the recovery trend.
Up to 1 year
Sensory difference as assessed by Semmes-Weinstein Monofilament test (unaffected hand - affected hand)
Time Frame: Up to 1 year

A quantitative method to systematically assess the threshold stimulus necessary for perception of light touch to deep pressure by using monofilaments of different sizes.

Interpretation scale for monofilaments:

2.83 Normal 3.61 Diminished light touch 4.31 Diminished protective sensation 4.56 Loss of protective sensation 6.65 Deep pressure sensation only Sensory thresholds will be measured at various time points to identify the recovery trend.

Up to 1 year
Complication rates for both surgical procedures assessed using a checklist
Time Frame: Up to 1 year
Complications will be categorized by type, severity, and frequency captured at Surgery, 2-Week, 6-Week, 3-Month, and 12 Month Visits.
Up to 1 year
Disease severity as measured by ulnar neuropathy at the elbow (UNE) severity scale
Time Frame: Enrollment, approximately day 0
Severity is determined based on responses to three parts sensory, motor, and test outcomes. Each part is scored 1-3, where 3=most disability.
Enrollment, approximately day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2020

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

January 31, 2020

First Submitted That Met QC Criteria

January 31, 2020

First Posted (Actual)

February 5, 2020

Study Record Updates

Last Update Posted (Actual)

July 11, 2023

Last Update Submitted That Met QC Criteria

July 10, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00133613
  • U01AR073485 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuropathy Ulnar

Clinical Trials on Simple decompression

3
Subscribe